Barbara Y. Chan
Director of Finance/CFO at OMEGA THERAPEUTICS, INC.
Profile
Barbara Y.
Chan is currently the Chief Financial & Accounting Officer at Omega Therapeutics, Inc. Prior to this role, she served as the President & Director at Aegerion Pharmaceuticals, Inc. and as the Chief Accounting Officer at Novelion Therapeutics, Inc. Ms. Chan completed her undergraduate and graduate degrees at Bentley University.
Barbara Y. Chan active positions
| Companies | Position | Start |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Director of Finance/CFO | 2024-05-30 |
Former positions of Barbara Y. Chan
| Companies | Position | End |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Comptroller/Controller/Auditor | 2019-09-23 |
| AEGERION PHARMACEUTICALS, INC. | President | - |
Training of Barbara Y. Chan
| Bentley University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Barbara Y. Chan
